Samad Hossain

Title: Samad Hossain: Innovator in Supramolecular Combinatorial Therapeutics

Introduction

Samad Hossain is a prominent inventor based in Delhi, India. He has made significant contributions to the field of supramolecular combinatorial therapeutics. His innovative work focuses on enhancing the efficacy of cancer treatments through advanced therapeutic compositions.

Latest Patents

Samad Hossain holds a patent for "Supramolecular Combinatorial Therapeutics." This patent relates to compositions that include hydrophobic taxane-lipid covalent conjugates. These conjugates create supramolecular assemblies within lipid bilayers, leading to increased intratumoral concentration and enhanced therapeutic efficacy. The patent also discusses the combination of taxane-lipid conjugates with platinum compounds, kinase inhibitors, and immunoregulators, which may also be conjugated with lipids.

Career Highlights

Samad Hossain is associated with Invictus Oncology Pvt. Ltd., where he continues to develop innovative therapeutic solutions. His work is pivotal in advancing cancer treatment methodologies, particularly through the use of supramolecular structures.

Collaborations

Some of his notable coworkers include Monideepa Roy and Aniruddha Sengupta. Their collaborative efforts contribute to the ongoing research and development in the field of oncology.

Conclusion

Samad Hossain's contributions to supramolecular combinatorial therapeutics represent a significant advancement in cancer treatment. His innovative approaches and collaborations are paving the way for more effective therapeutic options.